Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low Density Lipoprotein Cholesterol Level”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00846937
What this trial is testing

Plant Stanol Ester Beverage and Ileostoma Patients

Who this might be right for
Ileostoma
University of Helsinki 10
Early research (Phase 1)Study completedNCT01487460
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients

Who this might be right for
DyslipidemiaHealthy Volunteers
Novartis Pharmaceuticals 137
Not applicableLooking for participantsNCT06649240
What this trial is testing

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

Who this might be right for
Ischemic StrokeSmall Vessel Cerebrovascular DiseaseCholesterol, LDL+2 more
Seoul National University Hospital 4,016
Not applicableStudy completedNCT01020578
What this trial is testing

Low Density Lipoprotein (LDL) Cholesterol Metabolism in Impaired Glucose Tolerance

Who this might be right for
Impaired Glucose Tolerance
University of Sao Paulo General Hospital 29
Post-approval studies (Phase 4)Looking for participantsNCT05030818
What this trial is testing

Cross-over Study of Coronary Risk Factors With a Polypill

Who this might be right for
Coronary Artery Disease
Fundación EPIC 88
Large-scale testing (Phase 3)Not Yet RecruitingNCT07441317
What this trial is testing

QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 780
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Not applicableStudy completedNCT00535886
What this trial is testing

The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study

Who this might be right for
Cardiovascular DiseaseDiabetesDyslipidemia
UCSF Benioff Children's Hospital Oakland 15
Early research (Phase 1)Looking for participantsNCT07428473
What this trial is testing

STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Elevated LDL-C and High Cholesterol
Monash University 64
Testing effectiveness (Phase 2)Study completedNCT03549260
What this trial is testing

Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction

Who this might be right for
LDL Cholesterol
LIB Therapeutics LLC 81
Testing effectiveness (Phase 2)Study completedNCT01380730
What this trial is testing

LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy

Who this might be right for
Hyperlipidemia
Amgen 631
Large-scale testing (Phase 3)Not Yet RecruitingNCT07619118
What this trial is testing

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia

Who this might be right for
Hypercholesterolaemia
AstraZeneca 200
Large-scale testing (Phase 3)Study completedNCT04807400
What this trial is testing

Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

Who this might be right for
Atherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease Risk EquivelentsElevated Low Density Lipoprotein Cholesterol
Novartis Pharmaceuticals 892
Not applicableStudy completedNCT01200160
What this trial is testing

Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

Who this might be right for
Cardiovascular Diseases
Abbott 128
Large-scale testing (Phase 3)Study completedNCT07295418
What this trial is testing

SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hyperlipidemias
Shenzhen Salubris Pharmaceuticals Co., Ltd. 618
Early research (Phase 1)Study completedNCT05896969
What this trial is testing

Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol

Who this might be right for
Elevated Low-Density Lipoprotein Cholesterol
Syneos Health 41
Not applicableStudy completedNCT07748559
What this trial is testing

Impact of High-Oleic Palm Oil Consumption on Cardiovascular Biomarkers in Adults in Bogotá

Who this might be right for
Insulinemic ResponseType 2 Diabetes (Adult Onset)Hyperglycaemia (Diabetic)+1 more
Ruby Alejandra Villamil 52
Post-approval studies (Phase 4)Study completedNCT01122355
What this trial is testing

Comparison of Fenofibrate and Niacin in Patients With Hypertriglyceridemia and Low High-Density Lipoprotein (HDL)-Cholesterol

Who this might be right for
Hypertriglyceridemia With Low HDL-cholesterol
Yonsei University 240
Early research (Phase 1)Study completedNCT04774003
What this trial is testing

Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C

Who this might be right for
Hyperlipidemia
Novartis Pharmaceuticals 40
Early research (Phase 1)Looking for participantsNCT06164730
What this trial is testing

VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

Who this might be right for
Heterozygous Familial HypercholesterolemiaPremature Coronary Heart Disease
Verve Therapeutics, Inc. 85
Next Page